217 related articles for article (PubMed ID: 21658248)
1. Bactericidal activity of oxacillin and glycopeptides against Staphylococcus aureus in patients with endocarditis: looking for a relationship between tolerance and outcome.
Pasticci MB; Moretti A; Stagni G; Ravasio V; Soavi L; Raglio A; Vailati F; Cardaccia A; Santucci A; Papili R; Sgrelli A; Pallotto C; Baldelli F
Ann Clin Microbiol Antimicrob; 2011 Jun; 10():26. PubMed ID: 21658248
[TBL] [Abstract][Full Text] [Related]
2. Activity of glycopeptides against Staphylococcus aureus infection in a rabbit endocarditis model: MICs do not predict in vivo efficacy.
Asseray N; Jacqueline C; Le Mabecque V; Batard E; Bugnon D; Potel G; Caillon J
Antimicrob Agents Chemother; 2005 Feb; 49(2):857-9. PubMed ID: 15673789
[TBL] [Abstract][Full Text] [Related]
3. Failure of cloxacillin in treatment of a patient with borderline oxacillin-resistant Staphylococcus aureus endocarditis.
Skinner S; Murray M; Walus T; Karlowsky JA
J Clin Microbiol; 2009 Mar; 47(3):859-61. PubMed ID: 19116360
[TBL] [Abstract][Full Text] [Related]
4. Continuous versus intermittent infusion of oxacillin for treatment of infective endocarditis caused by methicillin-susceptible Staphylococcus aureus.
Hughes DW; Frei CR; Maxwell PR; Green K; Patterson JE; Crawford GE; Lewis JS
Antimicrob Agents Chemother; 2009 May; 53(5):2014-9. PubMed ID: 19258261
[TBL] [Abstract][Full Text] [Related]
5. In vitro combined bactericidal activity of cefpirome and glycopeptides against glycopeptides and oxacillin-resistant staphylococci.
Bergeret M; Boutros N; Raymond J
Int J Antimicrob Agents; 2004 Mar; 23(3):247-53. PubMed ID: 15164965
[TBL] [Abstract][Full Text] [Related]
6. Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis.
Cervera C; Castañeda X; de la Maria CG; del Rio A; Moreno A; Soy D; Pericas JM; Falces C; Armero Y; Almela M; Ninot S; Pare JC; Mestres CA; Gatell JM; Marco F; Miro JM;
Clin Infect Dis; 2014 Jun; 58(12):1668-75. PubMed ID: 24647021
[TBL] [Abstract][Full Text] [Related]
7. Influence of reduced susceptibility to glycopeptides on activities of vancomycin and teicoplanin against Staphylococcus aureus in experimental endocarditis.
Pavie J; Lefort A; Ploy MC; Massias L; Chau F; Garry L; Denis F; Fantin B
Antimicrob Agents Chemother; 2003 Jun; 47(6):2018-21. PubMed ID: 12760890
[TBL] [Abstract][Full Text] [Related]
8. New agents for Staphylococcus aureus endocarditis.
Drees M; Boucher H
Curr Opin Infect Dis; 2006 Dec; 19(6):544-50. PubMed ID: 17075329
[TBL] [Abstract][Full Text] [Related]
9. Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis.
Kaatz GW; Seo SM; Dorman NJ; Lerner SA
J Infect Dis; 1990 Jul; 162(1):103-8. PubMed ID: 2141343
[TBL] [Abstract][Full Text] [Related]
10. Microbiological and clinical study of methicillin-resistant Staphylococcus aureus (MRSA) carrying VraS mutation: changes in susceptibility to glycopeptides and clinical significance.
Kato Y; Suzuki T; Ida T; Maebashi K; Sakurai M; Shiotani J; Hayashi I
Int J Antimicrob Agents; 2008 Jan; 31(1):64-70. PubMed ID: 18029148
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial resistance of community and hospital acquired Staphylococcus aureus isolates to oxacillin and glycopeptides.
Anwar MS; Bokhari SR
J Coll Physicians Surg Pak; 2003 Jan; 13(1):33-6. PubMed ID: 12685973
[TBL] [Abstract][Full Text] [Related]
12. Frequency of mecA gene and borderline oxacillin resistant Staphylococcus aureus in nosocomial acquired methicillin resistance Staphylococcus aureus infections.
Khorvash F; Mostafavizadeh K; Mobasherizadeh S
Pak J Biol Sci; 2008 May; 11(9):1282-5. PubMed ID: 18819540
[TBL] [Abstract][Full Text] [Related]
13. Serum bactericidal titer as a predictor of outcome in endocarditis.
Hackbarth CJ; Chambers HF; Sande MA
Eur J Clin Microbiol; 1986 Feb; 5(1):93-7. PubMed ID: 2938947
[TBL] [Abstract][Full Text] [Related]
14. Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the "seesaw effect").
Yang SJ; Xiong YQ; Boyle-Vavra S; Daum R; Jones T; Bayer AS
Antimicrob Agents Chemother; 2010 Aug; 54(8):3161-9. PubMed ID: 20547804
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus.
Madrigal AG; Basuino L; Chambers HF
Antimicrob Agents Chemother; 2005 Aug; 49(8):3163-5. PubMed ID: 16048918
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of fosfomycin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
Pistella E; Falcone M; Baiocchi P; Pompeo ME; Pierciaccante A; Penni A; Venditti M
Infez Med; 2005 Jun; 13(2):97-102. PubMed ID: 16220029
[TBL] [Abstract][Full Text] [Related]
17. Activity of ampicillin-sulbactam and oxacillin in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.
Pefanis A; Thauvin-Eliopoulos C; Eliopoulos GM; Moellering RC
Antimicrob Agents Chemother; 1993 Mar; 37(3):507-11. PubMed ID: 8460919
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro activity of quinupristin/dalfopristin and seven other antimicrobials against methicillin-susceptible and methicillin-resistant nosocomial Staphylococcus aureus bloodstream isolates.
Nikolaidis P; Metallidis S; Katikaridou E; Chatzidimitriou M; Kollaras P; Tsona A; Koumentaki E; Tourkantonis A
J Chemother; 2002 Dec; 14(6):544-6. PubMed ID: 12583543
[TBL] [Abstract][Full Text] [Related]
19. Daptomycin is effective in treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
Marco F; de la Mària CG; Armero Y; Amat E; Soy D; Moreno A; del Río A; Almela M; Mestres CA; Gatell JM; Jiménez de Anta MT; Miró JM;
Antimicrob Agents Chemother; 2008 Jul; 52(7):2538-43. PubMed ID: 18426900
[TBL] [Abstract][Full Text] [Related]
20. Comparison of methicillin, nafcillin, and oxacillin in therapy of Staphylococcus aureus endocarditis in rabbits.
Egert J; Carrizosa J; Kaye D; Kobasa WD
J Lab Clin Med; 1977 Jun; 89(6):1262-8. PubMed ID: 864305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
